5.10
Precedente Chiudi:
$4.85
Aprire:
$4.81
Volume 24 ore:
7,369
Relative Volume:
0.23
Capitalizzazione di mercato:
$22.66M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.00%
1M Prestazione:
+3.75%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Callan Jmb Inc Stock (CJMB) Company Profile
Nome
Callan Jmb Inc
Settore
Industria
Telefono
(830) 438-0395
Indirizzo
244 FLIGHTLINE DRIVE, SPRING BRANCH
Confronta CJMB con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
CJMB
Callan Jmb Inc
|
5.10 | 22.66M | 0 | 0 | 0 | 0.00 |
![]()
UPS
United Parcel Service Inc
|
98.25 | 82.60B | 90.91B | 5.86B | 5.37B | 6.86 |
![]()
FDX
Fedex Corp
|
219.61 | 52.26B | 87.82B | 3.92B | 3.43B | 15.94 |
![]()
EXPD
Expeditors International Of Washington Inc
|
112.36 | 15.44B | 11.06B | 844.72M | 765.64M | 6.02 |
![]()
ZTO
Zto Express Cayman Inc Adr
|
17.13 | 14.05B | 6.17B | 1.23B | 1.59B | 1.4906 |
![]()
JBHT
J B Hunt Transport Services Inc
|
140.21 | 13.77B | 12.06B | 561.13M | 513.08M | 5.51 |
Callan Jmb Inc Borsa (CJMB) Ultime notizie
Callan JMB Supports Texas and New Mexico with Measles - GlobeNewswire
Callan JMB Inc. Supports Texas and New Mexico with Measles Outbreak Response Through Redistribution of MMR II Vaccines - marketscreener.com
Callan JMB Supports Texas and New Mexico with Measles Outbreak Response through Redistribution of MMR II Vaccines - Yahoo
Callan JMB to Participate in Maxim Group’s 2025 Virtual Tech Conference on June 3-5, 2025 - GlobeNewswire
Callan JMB and Revival Health launch joint venture for healthcare logistics - Investing.com Canada
Callan Jmb Inc. and Revival Health Inc. Form Joint Venture to Strengthen U.S. Supply Chain for Vital Health, Wellness and Longevity Products - marketscreener.com
Callan JMB, Revival Health Launch Joint Venture for US Supply Chain - marketscreener.com
Callan JMB and Revival Health Form Joint Venture to - GlobeNewswire
Callan JMB First Quarter 2025 Earnings: US$0.32 loss per share (vs US$0.032 loss in 1Q 2024) - Yahoo Finance
Callan JMB Announces Participation in the Aegis Capital Corp. Virtual Conference 2025 on May 21, 2025 - GlobeNewswire
Callan JMB Appoints Interim CFO After Termination - TipRanks
Callan JMB Inc As Of May 13, Terminates CFO Jeffrey Appleman Effective Immediately - marketscreener.com
Callan JMB Inc. Completes IPO with Gross Proceeds of Approximately $5.7 Million and Provides Business Update - Nasdaq
Callan JMB Announces First Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Callan JMB Announces First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire Inc.
Callan JMB Awarded Second 5-Year Contract by the Oregon Health Authority for Emergency Preparedness and Response after Successful Operations for COVID-19 and MPOX Pandemics - The Globe and Mail
Callan JMB Announces Participation in LD Micro Invitational Conference on April 9-10th in New York City - The Globe and Mail
Callan JMB Announces Closing of $5.12 Million Initial Public Offering - The Globe and Mail
Callan JMB Insiders May Regret Not Buying More, Market Cap Hits US$23m - Yahoo Finance
Insiders Buying Callan JMB Might Wish They Invested More, Stock Gains 16% - simplywall.st
Callan JMB Appoints Christopher Shields as Senior Vice President of Emergency Preparedness & Response/Government Affairs - citybiz
Callan JMB Appoints Former Assistant Commissioner of - GlobeNewswire
Callan JMB Appoints Former Assistant Commissioner of Chicago Department of Health, Christopher Shields, as Senior Vice President of Emergency Preparedness & Response/Government Affairs - The Manila Times
Callan JMB chief medical officer David Croyle buys $112,500 in stock - Investing.com India
Top Executive Makes Bold Move with Major Stock Purchase! - TipRanks
Callan JMB chief medical officer David Croyle buys $112,500 in stock By Investing.com - Investing.com South Africa
CALLAN JMB INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus
Callan JMB Announces Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire
Callan JMB Inc. (CJMB) reports earnings - Quartz
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025 - The Globe and Mail
12 Industrials Stocks Moving In Monday's After-Market Session - Benzinga
Top Executives Make Bold Moves with Major Stock Purchases in Callan JMB, Inc. - TipRanks
Callan JMB chief medical officer David Croyle buys $97,500 in stock - Investing.com Australia
Callan JMB CEO Wayne Williams acquires $252,500 in stock By Investing.com - Investing.com Australia
Callan JMB chief medical officer David Croyle buys $97,500 in stock By Investing.com - Investing.com South Africa
Callan JMB CEO Wayne Williams acquires $252,500 in stock - Investing.com India
Callan JMB Insider Bought Shares Worth $252,500, According to a Recent SEC Filing -March 14, 2025 at 08:48 am EDT - Marketscreener.com
Callan JMB to Participate in Upcoming March Conferences - GlobeNewswire
Callan Jmb Inc.’s (NASDAQ:CJMB) Quiet Period Will End on March 17th - Defense World
Callan JMB Receives Request From The State Of Texas Department Of Health And Human Services To Be On Standby In Response To Measles Outbreak - Marketscreener.com
Callan JMB Receives Request from the State of Texas Department of Health and Human Services to be on Standby in Response to Measles Outbreak - The Manila Times
Callan JMB Receives Request from the State of Texas - GlobeNewswire
Callan JMB Unveils Innovative Immunization Management - GlobeNewswire
Callan Jmb Inc Azioni (CJMB) Dati Finanziari
Non sono disponibili dati finanziari per Callan Jmb Inc (CJMB). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Callan Jmb Inc Azioni (CJMB) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Williams Wayne D | CEO and President |
Feb 05 '25 |
Buy |
4.00 |
50,625 |
202,500 |
25,625 |
Williams Wayne D | CEO and President |
Feb 05 '25 |
Buy |
4.00 |
12,500 |
50,000 |
2,262,500 |
Croyle David J | Chief Medical Officer |
Feb 05 '25 |
Buy |
4.00 |
24,375 |
97,500 |
24,375 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):